Purification and characterization of prokaryotically expressed human interferon-λ2

Biotechnology Letters

Volumn 29, Issue 7, 2007, Pages 1025-1029

  Li, Mingcai ^a   Huang, Dongyang ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Antiviral activity; Enterokinase; Interferon 2; Ni NTA affinity chromatography; Recombinant protein

Indexed keywords

ANTIVIRAL ACTIVITY; ENTEROKINASE; INTERFERON-2; NI-NTA AFFINITY CHROMATOGRAPHY; RECOMBINANT PROTEIN;

AFFINITY CHROMATOGRAPHY; ESCHERICHIA COLI; GENE EXPRESSION; PURIFICATION;

PROTEINS;

ANTIVIRUS AGENT; CYTOKINE; IL28A PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; DRUG EFFECT; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROKARYOTIC CELL;

ANTIVIRAL AGENTS; CELL LINE; CYTOKINES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPITHELIAL CELLS; GENE EXPRESSION; HUMANS; INTERLEUKINS; PLASMIDS; PROKARYOTIC CELLS; RECOMBINANT PROTEINS;

ESCHERICHIA COLI;

EID: 34249035887     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-007-9357-y     Document Type: Article

References (15)

1. Bartlett NW, Buttigieg K, Kotenko SV, Smith GL (2005) Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model. J Gen Virol 86:1589-1596
2. Brand S, Zitzmann K, Dambacher J, Beigel F, Olszak T, Vlotides G, Eichhorst ST, Goke B, Diepolder H, Auernhammer CJ (2005) SOCS-1 inhibits expression of the antiviral proteins 2',5'-OAS and MxA induced by the novel interferon-lambdas IL-28A and IL-29. Biochem Biophys Res Commun 331:543-548
3. Coccia EM, Severa M, Giacomini E, Monneron D, Remoli ME, Julkunen I, Cella M, Lande R, Uze G (2004) Viral infection and Toll-like receptor agonists induce a differential expression of type I and λ interferon as in human plasmacytoid and monocyte-derived dendritic cells. Eur J Immunol 34:796-805
4. Davis GD, Elisee C, Newham DM, Harrison RG (1999) New fusion protein systems designed to give soluble expression in Escherichia coli. Biotechnol Bioeng 65:382-388
5. Dumoutier L, Tounsi A, Michiels T, Sommereyns C, Kotenko SV, Renauld JC (2004) Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling. J Biol Chem 279:32269-32274
6. 4Lys on enterokinase cleavage of fusion protein. Anal Biochem 169:10-16
7. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, Langer JA, Sheikh F, Dickensheets H, Donnelly RP (2003) IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4:69-77
8. Li M, Wang H, Wang H, Li T, He S (2006a) Liposome mediated IL-28 and IL-29 expression in A549 cells and the antiviral effect of IL-28 and IL-29 on WISH cells. Acta Pharmacol Sin 27:453-459
9. Li M, Feng Z, Zhang G, Li D (2006b) High-level expression of a recombinant fragment of human fibronectin containing the Cell I-Hep II-IIICS71 domain in Escherichia coli as a soluble protein. Biotechnol Lett 28:1141-1146
10. Li M, He S (2006) Purification and characterization of recombinant human interleukin-29 expressed in Escherichia coli. J Biotechnol 122:334-340
11. Meager A, Visvalingam K, Dilger P, Bryan D, Wadhwa M (2005) Biological activity of interleukins-28 and -29: Comparison with type I interferons. Cytokine 31:109-118
12. Mennechet FJ, Uze G (2006) Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells. Blood 107:4417-4423
13. Robek MD, Boyd BS, Chisari FV (2005) Lambda interferon inhibits hepatitis B and C virus replication. J Virol 79:3851-3854
14. Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, Kuestner R, Garrigues U, Birks C, Roraback J, Ostrander C, Dong D, Shin J, Presnell S, Fox B, Haldeman B, Cooper E, Taft D, Gilbert T, Grant FJ, Tackett M, Krivan W, McKnight G, Clegg C, Foster D, Klucher KM (2003) IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4:63-68
15. Siren J, Pirhonen J, Julkunen I, Matikainen S (2005) IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29. J Immunol 174:1932-1937